Drugs that contain Spinosad
1. Natroba patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US5496931 | PARAPRO LLC | Insecticide and miticide A83543 compounds and their method of production by fermentation |
Mar, 2013
(11 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6342482 | PARAPRO LLC | Formulations for controlling human lice |
Jun, 2019
(4 years ago) | |
| US7030095 | PARAPRO LLC | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
Jul, 2021
(2 years ago) | |
| US6063771 | PARAPRO LLC | Formulations for controlling human lice |
Jul, 2023
(8 months ago) | |
| US9895388 | PARAPRO LLC | Methods and compositions useful for controlling cutaneous mites |
Nov, 2033
(9 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Indication(I-858) | Apr 28, 2024 |
| M(M-152) | Nov 30, 2017 |
| New Chemical Entity Exclusivity(NCE) | Jan 18, 2016 |
NCE-1 date: 18 January, 2015
Market Authorisation Date: 18 January, 2011
Treatment: Topical treatment of head lice infestation in patients four (4) years of age and older; Natroba topical suspension is a pediculicide indicated for the topical treatment of head lice infestation in pat...
Dosage: SUSPENSION;TOPICAL
More Information on Dosage
NATROBA family patents
